|
Volumn 19, Issue 2, 2014, Pages 131-132
|
Underpinnings of cellular organ replacement therapies
|
Author keywords
[No Author keywords available]
|
Indexed keywords
INSULIN;
ORAL ANTIDIABETIC AGENT;
BLOOD GLUCOSE MONITORING;
CELL ORGANELLE;
CELL THERAPY;
EDITORIAL;
END STAGE RENAL DISEASE;
EXTRACELLULAR MATRIX;
HUMAN;
KIDNEY CELL;
KIDNEY EPITHELIUM;
KIDNEY FUNCTION;
KIDNEY TRANSPLANTATION;
MESENCHYMAL STEM CELL;
ORGAN TRANSPLANTATION;
PANCREAS ISLET TRANSPLANTATION;
PLURIPOTENT STEM CELL;
SUBSTITUTION THERAPY;
BIOARTIFICIAL ORGANS;
CELL- AND TISSUE-BASED THERAPY;
HUMANS;
ORGAN CULTURE TECHNIQUES;
ORGANOGENESIS;
TISSUE ENGINEERING;
TISSUE SCAFFOLDS;
|
EID: 84897110891
PISSN: 10872418
EISSN: 15317013
Source Type: Journal
DOI: 10.1097/MOT.0000000000000056 Document Type: Editorial |
Times cited : (1)
|
References (10)
|